Teva Announces Settlement with Aurobindo Resolving AUSTEDO® (deutetrabenazine) Patent Dispute
TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)–Teva Branded Pharmaceutical Products R&D, Inc. and Auspex Pharmaceuticals, Inc., U.S. affiliates of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), have reached an agreement with Aurobindo to resolve the dispute over Aurobindo’s Abbreviated New Drug Application (“ANDA”) for a generic deutetrabenazine product. Teva and Aurobindo have been involved … [Read more…]
